Metagenomi, Inc. Common Stock
MGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$78,058 | -$68,255 | -$43,593 | -$21,442 |
| Dep. & Amort. | $5,407 | $4,207 | $1,733 | $387 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $16,204 | $6,922 | $1,962 | $375 |
| Change in WC | -$59,668 | -$26,429 | $69,487 | $46,255 |
| Other Non-Cash | $7,042 | -$7,854 | $135 | -$1,318 |
| Operating Cash Flow | -$109,073 | -$91,409 | $29,724 | $24,257 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,114 | -$9,814 | -$13,977 | -$2,903 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$306,420 | -$208,096 | -$214,850 | -$71,413 |
| Inv. Sales/Matur. | $221,377 | $263,644 | $106,627 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$88,157 | $45,734 | -$122,200 | -$74,316 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $29,974 |
| Stock Issued | $84,013 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1,012 | $239,594 | $9,948 |
| Financing Cash Flow | $84,013 | $1,012 | $239,594 | $39,922 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$113,217 | -$44,663 | $147,118 | -$10,137 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $145,851 | $190,514 | $43,396 | $53,533 |
| End Cash | $32,634 | $145,851 | $190,514 | $43,396 |
| Free Cash Flow | -$112,187 | -$101,223 | $15,747 | $21,354 |